SCHEMBL4999735

SCHEMBL4999735

C[C@H]1CCCN(C(=O)c2cc3cc(F)ccc3[nH]2)C1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.64
HRH4 Q9H3N8 2/20 0.63
KMT2A Q03164 4/20 0.61
MEN1 O00255 3/20 0.61
TP53 P04637 1/20 0.57
FPR2 P25090 1/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
KDM4E B2RXH2 1/20 0.52
PDPK1 O15530 1/20 0.52
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
HPGD P15428 1/20 0.52
TSHR P16473 1/20 0.52
NFKB1 P19838 1/20 0.52
APEX1 P27695 1/20 0.52
CYP2C19 P33261 1/20 0.52
HSD17B10 Q99714 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
MLLT1 Q03111 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12334098 0.91 MAPT (0.57) MAPTHRH4KMT2AMEN1TP53
SCHEMBL27836005 0.86 MAPT (0.70) MAPTHRH4KMT2AMEN1FPR2
SCHEMBL27836006 0.84 MAPT (0.62) MAPTHRH4KMT2AMEN1FPR2
SCHEMBL4999923 0.84 HRH4 (0.65) MAPTHRH4KMT2AMEN1TP53
SCHEMBL2351433 0.84 HRH4 (0.78) MAPTHRH4KMT2AMEN1NPC1
SCHEMBL2347252 0.82 HRH4 (0.76) MAPTHRH4KMT2AMEN1NPC1
SCHEMBL29991093 0.81 HRH4 (0.62) MAPTHRH4KMT2AMEN1FPR2
SCHEMBL21225313 0.81 HRH4 (0.62) MAPTHRH4KMT2AMEN1FPR2
SCHEMBL21225315 0.81 HRH4 (0.62) MAPTHRH4KMT2AMEN1FPR2
SCHEMBL4338439 0.81 HRH4 (0.65) MAPTHRH4KMT2AMEN1FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221114-A1 2-(Cyclic Aminocarbonyl) Indoline Derivative and Medicinal Composition Containing the Same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-09-11 US disclosed
CN-101103019-A 2- (Cyclic aminocarbonyl) indoline derivative and pharmaceutical composition containing same DAINIPPON SUMITOMO PHARMA CO (JP) 2008-01-09 CN disclosed
EP-1840126-A1 2-(CYCLIC AMINOCARBONYL)INDOLINE DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THE SAME Dainippon Sumitomo Pharma Co., Ltd. (JP) 2007-10-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221114-A1 2-(Cyclic Aminocarbonyl) Indoline Derivative and Medicinal Composition Containing the Same CYP11B2, CYP11B1, GRIN2A MAPT 549/4885HRH4 138/4885KMT2A 1437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.